Clinical Trial Update: R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma [NA]

View source ↗

Summary

This clinical trial evaluates robotic-assisted retroperitoneal lymph node dissection (R-RPLND) as first-line treatment for clinical stage IIA/B testicular semin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Seminoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma | NA | Status: RECRUITING